INTRODUCTION
In the United States, 36,100 women will develop endometrial cancer in 2000, and an estimated 6500 women will die of this disease [1] . Endometrial cancer is statistically a tumor of the postmenopausal period, with a mean age at diagnosis of 63.1 years [2] . Previous studies suggest that between 2 and 14% of patients with endometrial cancer will be 40 years of age or younger [3] [4] [5] [6] [7] [8] [9] [10] .
The diagnosis of endometrial cancer in a young woman is typically associated with a hyperestrogenic state. The "classic" young woman with endometrial cancer is obese, nulliparous, and anovulatory. The tumors are often positive for estrogen receptor, which is believed to be a good prognostic indicator [11] . In contrast is the young woman with endometrial cancer who is slim with regular menstrual cycles. Her endometrial cancer presumably does not develop as a consequence of continued estrogen stimulation and has traditionally been believed to have a worse prognosis than that of the women with an estrogen excess stimulated tumor.
Hysterectomy with bilateral salpingo-oophorectomy is the standard treatment for this disease. Nevertheless, medical treatment and uterine sparing for the purpose of future fertility have been reported in the literature as being safe under certain circumstances [12] [13] [14] [15] [16] . Clear, unequivocal guidelines for identifying those women for whom uterine conservation is appropriate do not exist, however. Many physicians are uncomfortable counseling the slender woman about medical therapy because of a fear that she may have a more aggressive tumor than her obese counterpart.
The purpose of the current study was to review retrospectively the experience at one institution in treating women age 40 or younger with endometrial cancer. The primary goal was to determine the clinical characteristics of these women, with a focus on body-mass index (BMI). Secondary goals were to (1) use immunohistochemistry techniques to help categorize the nature of these tumors at a molecular level and (2) describe a small series of women treated with medical therapy and uterine conservation. Her-2-neu and estrogen and progesterone receptors (ER and PR) were specifically considered because of their association with prognosis and, in the case of PR, with success of hormonal therapy. Introduction Administration of clomiphene citrate was unsuccessful in Endometrial carcinoma is the most common malignancy of establishing ovulation. Gonadotrophin-induced ovulation was the lower female genital tract. In 1994, the estimated incidence also unsuccessful in achieving a conception after three attempts. of endometrial cancer was 8% of all female cancers (Boring In-vitro fertilization (IVF) and embryo transfer were finally et al., 1994) . However, only 5% of all patients who develop attempted. At baseline scan, performed early in the follicular endometrial adenocarcinoma are under 40 years of age (Ostor phase of the cycle, the endometrium was noted to be 13 mm et al., 1982) . Anovulatory polycystic ovarian syndrome (PCOS) in thickness with otherwise normal morphology. Hence, downis associated with endometrial carcinoma due to the prolonged regulation with buserelin was commenced. After 4 weeks and unopposed effect of oestrogen on the endometrium (Wood of buserelin administration the patient menstruated which and Boronow, 1976; Silverberg et al., 1977; Greenblatt et al., suggested a fall in endogenous oestradiol concentration and 1982; Tsoutsoplides, 1983) . This was recently highlighted by down-regulation of the pituitary. The endometrium, although Meirow and Schenker (1996) , who analysed all case reports still 8 mm in thickness, had diminished by this stage. Controlled and epidemiological studies examining the link between inferovarian hyperstimulation with 300 IU of urinary follicletility and endometrial cancer. They showed anovulation to be stimulating hormone daily was commenced. An adequate the main cause of the increased risk of endometrial carcinoma ovarian response was obtained and human chorionic gonadotroin infertile patients. PCOS is a common disorder which is phin (5000 IU) was administered on day 11 of the stimulation thought to be present in up to 22% of all young women (Insler phase. On the day of egg collection, 19 oocytes were collected, and Lunenfield, 1991; Balen et al., 1995) . In addition, ovulatory of which 14 were fertilized normally and 13 of these cleaved. dysfunction causes subfertility in 15-20% of couples (Hull Embryo transfer was planned 48 h post egg collection. et al., 1985) . Furthermore, approximately 50% of all subfertile female patients diagnosed as having 'unexplained' infertility At the time of embryo transfer, a small but steady trickle are subsequently found to have ovulatory dysfunction similar of blood was noted as soon as the embryo transfer catheter to that of PCOS. In this case report we emphasise the was introduced into the uterine cavity. There had been no importance of having a high level of suspicion that endometrial trauma in the insertion of the catheter which could have disease may be present in such patients and discuss the various explained this loss. Hence this unprovoked bleeding was treatment options and their drawbacks.
thought to be suspicious and merited further investigations. The embryo transfer was abandoned and all the embryos Case report were frozen. Cervical cytology and colposcopy were negative. Therefore, A 32 year old woman with a five year history of primary subfertility was referred to the Assisted Conception Unit for examination under anaesthesia, hysteroscopy and dilatation overweight, with a body mass index of 37 (normal rang 3 To whom correspondence should be addressed 25). Abdomino-pelvic examination was normal and her Adenocarcinoma of the endometrium is a rare condition cervical smear test had been negative. Blood tests for th in women under 40 years of age. However, patients with function, random glucose and prolactin concentrations anovulatory polycystic ovarian syndrome are at risk of normal. The plasma luteinizing hormone and free testost developing endometrial carcinoma due to the unopposed values were elevated and luteal phase progesterone was co and prolonged effect of oestrogen on the endometrium.
ently anovulatory (Table I) . A transvaginal ultrasound This case report discusses the dilemma of various treatment showed a normal looking endometrium but the ovaries h options for early disease in such patients.
characteristic 'pearl necklace' appearance, with periphe Key words: endometrial adenocarcinoma/polycystic ovarian located follicles and dense echogenic stroma. The diag syndrome/infertility/IVF of polycystic ovarian syndrome was thus confirmed. La scopy and dye demonstrated a normal pelvis with patent and her partner's semen analysis was normal.
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Safety of fertility-sparing treatment
There were 20 diagnoses of ovarian malignancy during follow-up (20 of 559, 3.6%), and it was not always clear from the primary studies whether they represented concurrent ovarian malignancies or metastatic ovarian involvement from the endometrial primary neoplasm. The type of ovarian cancer and staging was poorly reported, but 10 women were diagnosed with endometrioid adenocarcinoma of the ovary (10 of 559, 1.8%).
The preoperative imaging or tumor marker investigations did not appear to reduce this incidence because in 11 studies that carried out these investigations, ovarian malignancy was diagnosed during follow-up in 8 women (8 of 200, 4%) compared with 13 studies in which only imaging was used, and there were 5 ovarian malignancies diagnosed (5 of 217, 2.3%), and in 10 studies with no such investigations, there were 7 ovarian malignancies diagnosed (7 of 142, 4.9%).
There were also 10 women (10 of 559, 1.8%) diagnosed with stage II EC or higher after failing treatment. In 1 case there was a distal lymphatic metastasis involving the obturator lymphatic node.22 There were 2 deaths from fertility-sparing treatment for
FIGURE 3
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Study
An additional encouraging proportion of women choosing this treatment for preserving their fertility managed to achieve live births (28% of women with EC and 26% of women with ACH). Women choosing assisted reproductive treatment had significantly better results, regardless of the initial diagnosis. However, the relapse rates during follow-up are worrying (41% for EC and 26% for ACH). The incidence of ovarian malignancies in 20 women during follow-up is also worrying (3.6%), and the preoperative imaging or CA-125 testing, even though essential, did not lower this incidence. The upgrade of disease in a further 10 cases along with distant metastases in 2 of these cases also represents a considerable risk of this treatment. There were 2 deaths reported.
FIGURE 4
Forest plot of metaanalysis of relapse rates for fertility-sparing treatment of endometrial cancer
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Elizur (2007) Gotlieb (2003) Han (2009 Jadoul (2003) Kaku (2001) Kim (2000) Laurelli (2011) Le Digabel (2006) Li ( Mao (2010) Mazzon (2010) Minaguchi (2007) Minig (2010) Niwa (2005) Perri ( (2009) Ushijima (2007) Wang (2002) Wheeler (2007) Yahata ( [25, 178] 57 [29, 114] 50 [19, 133] 14 [2, 101] 100 [48, 210] Yamazawa (2007) Yang (2005) Yu (2009) Endometrial cancer is the most common malignancy of the female genital tract. It has been estimated that cancer of the uterus will develop in 2.6% of women in the United States during their lifetime, with a 0.5% lifetime mortality risk (1). Although endometrial cancer tends to be diagnosed in older, postmenopausal women with a mean age of 63 years, between 5% and 29% of endometrial cancers are diagnosed in women who are %40 years of age (2).
Total abdominal hysterectomy and bilateral salpingo-oophorectomy with lymph-node assessment is the gold standard treatment of an early stage, well-differentiated (International Federation of Gynecology and Obstetrics [FIGO] grade 1) endometrial cancer with a cure rate at 5 years that exceeds 90% (3). However, surgical treatment is associated with loss of fertility in young women. For young patients who desire future fertility, conservative management of uterine cancer has been advocated as a safe alternative to hysterectomy and bilateral salpingo-oophorectomy. Medical treatment and uterine (4-6) and led to pregnancy (7). However, unequivocal guidelines for treatment in those women for whom uterine conservation is appropriate do not exist. In this report, we describe six women with a solitary, well-differentiated endometrial adenocarcinoma who refused hysterectomy at time of diagnosis and consequently underwent conservative treatment by hysteroscopic tumor resection followed by progestinic therapy.
MATERIALS AND METHODS
Between September 2001 and September 2007 six premenopausal patients with a strong desire to preserve their fertility potential were enrolled for conservative therapy with hysteroscopic resection of the tumor followed by a hormone therapy regimen of megestrol acetate (160 mg/day) for 6 months. Inclusion criteria were age <40 years, nulliparous, confirmed endometrial adenocarcinoma with grade 1 differentiation by diagnostic hysteroscopy with biopsy, presence of P receptor, and absence of myometrial invasion or extra-Eligible patients were counseled extensively for the option of conservative therapy and the possibility of recurrence or progression of disease. After informed consent was obtained, an operative hysteroscopy was performed with the patients under general anesthesia; the cervix was dilated to 10 mm with Hegar's dilator, and a 9 mm resectoscope with 0 lens was introduced. The uterus was distended with 1.5% glycine solution under gravity inflow of 70 mm Hg pressure. Irrigant fluid was collected in 3-L graduated cylinders and monitored carefully. A 5-mm cutting loop electrode and 100 W of pure cutting output power were used to resect the tumor lesion, the endometrium near the lesion, and the myometrium under lesion.
If the pathologic analysis confirmed a well-differentiated adenocarcinoma of the endometrium with no invasion of myometrium and of resection margins, hormone therapy regimen of megestrol acetate (160 mg) daily was initiated 5 days after operative hysteroscopy and continued for 6 months. Patients were allowed to attempt childbearing immediately after completing their therapy with megestrol acetate.
Complete response was defined as total absence of tumor cells during the follow-up diagnostic hysteroscopy with biopsy after hormone therapy. If the patient did not respond on the first assessment, the plan was to switch to traditional surgery.
After documentation of complete remission, the patients then were closely followed up in the outpatient clinic. Vaginal ultrasonography and diagnostic hysteroscopy with biopsy were performed every 3 months for the first year and every 6 months for the next 2 years. Table 1 . Median patient age was 33 years (range 27-39 years). None of the patients was obese; four out of six referred a primary infertility.
RESULTS

Clinical characteristics of patients are detailed in
Pathologic diagnoses at diagnostic hysteroscopy were six grade 1 endometrioid adenocarcinoma FIGO stage IA. All tumors were estrogen and progestin receptor positive.
Median follow-up time was 50.5 months (range 21-82 months). None of these patients had any problem during and after both endoscopic surgery and hormonal therapy. All patients responded to conservative therapy after 3 months of hormonal therapy, and none had recurrent disease during the follow-up time ( Table 2 ).
As with most young patients with endometrial cancer, our patients were nulliparous at diagnosis. At present, four out of six have given birth to five infants, 24 months on average from the end of therapy (range 14-46 months) without assisted reproductive technology (ART). The other two actively are attempting to conceive.
One patient had two pregnancies. Four babies were born by cesarean section at 39 weeks of gestation, and one was born spontaneously at 41 weeks. Four out of five were male, and the average weight was 3,600 g (range 3,200-4,500 g). Of the two patients who are not pregnant yet, one is undergoing several fertility tests to establish whether she would be able to get pregnant, whereas the second one because of changes in her personal life decided to forgo pregnancy altogether. After counseling with these patients, three out of six declared not to 
MRI?
1-For the detection of myometrial invasion, contrast-enhanced MRI, is superior to ultrasonography and computed tomography scan ( Sensitivity and specifity of 74% ) 2-MRI can also be used to evaluate lymph nodes. Lymph nodes over 1 cm and with central necrosis are suspicious. 
CONCLUSION:
Careful preoperative and intraoperative assessment of the adnexa is mandatory in young women with endometrial cancer. Those who desire ovarian preservation should be counseled regarding the high rate of coexisting ovarian malignancy. (Obstet Gynecol 2005; 106:693-9) LEVEL OF EVIDENCE: II-3 T he diagnosis of endometrial cancer in a young, premenopausal woman may present the patient and her physician with the question of conservative management or ovarian preservation. Standard treatment includes hysterectomy and bilateral salpingooophorectomy (BSO) and results in an abrupt loss of fertility as well as surgical menopause with its attendant symptoms. The option of conservative treatment with progestins, usually in the context of fertility preservation, has been advocated as a safe alternative by a number of groups. 1-7 However, there are also reports of a higher incidence of ovarian malignancy in this young subset of women who may be considering uterine or ovarian preservation, with a range of 5 to 29% reported in the literature. 8 -11 Knowledge of the potential risk for a coexisting ovarian malignancy has important implications for counseling and management of young patients with endometrial cancer. Our objectives in this study were to determine the frequency of coexisting ovarian malignancies in young women with endometrial cancer and to identify predictors for coexisting ovarian malignancy that might assist with clinical decision making.
MATERIALS AND METHODS
Institutional review board approval was obtained at Cedars-Sinai Medical Center, University of California Los Angeles Medical Center, Olive View-UCLA, and
See related editorial on page 680. 
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OBJECTIVE:
In premenopausal women with endometrial cancer, ovarian preservation may be a consideration. Our objective was to examine the occurrence of coexisting ovarian malignancy and to identify predictors of adnexal involvement. 
METHODS:
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Complete remission?
Total absence of tumor cells during the follow-up diagnostic hysteroscopy with biopsy after hormone therapy! If the patient does not respond on the first assessment, recomendation to switch to traditional surgery should be performed.
A thinning of the endometrium as seen on transvaginal ultrasound is associated with an increased chance of responding to progestin therapy. 
Introduction
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ently anovulatory (Table I) . A transvaginal ultrasound scan This case report discusses the dilemma of various treatment showed a normal looking endometrium but the ovaries had the options for early disease in such patients.
characteristic 'pearl necklace' appearance, with peripherallyKey words: endometrial adenocarcinoma/polycystic ovarian located follicles and dense echogenic stroma. The diagnosis syndrome/infertility/IVF of polycystic ovarian syndrome was thus confirmed. Laparoscopy and dye demonstrated a normal pelvis with patent tubes and her partner's semen analysis was normal.
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thought to be suspicious and merited further investigations. The embryo transfer was abandoned and all the embryos were frozen. Cervical cytology and colposcopy were negative. Therefore, ith a five year history of primary to the Assisted Conception Unit for examination under anaesthesia, hysteroscopy and dilatation [21, 22, 34] . A trial of conservative management with medical therapy, usually progestins, may be considered in young women to induce tumor regression and hence preserve fertility [20] . Progestin therapy is often an effective treatment for endometrial hyperplasia [5, [22] [23] [24] , and a growing body of evidence supports progestin therapy to treat endometrial carcinoma in young women.
Endometrial cancer in reproductive age women
Multiple case reports and case series demonstrate the conservative management of endometrial cancer in young women. A number of case reports discuss women, often infertile, diagnosed with well differentiated endometrial adenocarcinomas, conservatively treated with high-dose progestin therapy, who conceived after documented regression of the malignancy [4,11,12 • ,14,15,24,26,35 • ,36-42] . For some women, post-partum serial endometrial samplings [12 • ,24,26,38, 39,41,42] or hysterectomy [4, 11, 36] revealed no evidence of disease. Less optimal and poor outcomes, however, have also occurred such as a synchronous ovarian malignancy at post-partum hysterectomy [14] . A focus of well differentiated endometrial carcinoma at post-partum hysterectomy that persisted despite promanagement of endometrial carcinoma in young women (Table 1) . Recently, Gotlieb et al. [20] identified 13 of 75 nulliparous patients (18%), age range 23-40 years, with grade 1 and grade 2 endometrial cancers treated with progestins after thorough evaluations revealed no evidence of extrauterine disease. Within 3 months, 10 of 13 women (77%) showed an initial response and, by 8 months, all 13 women had responded favorably. Five patients developed a local recurrence at a median of 40 months (range 19-358 months). Three patients responded to a second course of progestins, one of whom conceived and had a post-partum recurrence (stage IA at hysterectomy) and two patients had no progression of disease upon TAH-BSO. Three women delivered nine viable children, several pregnancies were ongoing, and several women had started fertility therapy. In this study, conservative treatment with progestins did not worsen the stage or grade of endometrial carcinoma, and this delay of definitive surgical management enabled successful pregnancies [20] . Other authors have discussed various methods of conservative management of grade I endometrial cancers in young women and reported similar results and conclusions, including effective medical treatment of disease recurrence and successful pregnancies [5, 17, [21] [22] [23] 
Disease free window!
The available data suggest relative safety and efficacy of progestin treatment for a short window to allow the woman to achieve her reproductive goals!
INTRODUCTION
The purpose of the current study was to review retrospectively the experience at one institution in treating women age 40 or younger with endometrial cancer. The primary goal was to determine the clinical characteristics of these women, with a focus on body-mass index (BMI). Secondary goals were to (1) use immunohistochemistry techniques to help categorize the nature of these tumors at a molecular level and (2) describe a small series of women treated with medical therapy and uterine conservation. Her-2-neu and estrogen and progesterone receptors (ER and PR) were specifically considered because of their association with prognosis and, in the case of PR, with success of hormonal therapy.
